Overview

A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users

Status:
Active, not recruiting

Trial end date:
2022-11-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the abuse potential and pharmacokinetics of PF614 compared with a non-abuse deterrent, commercially available, immediate release (IR) oxycodone hydrochloride (HCl) formulation and placebo.

Phase:

Phase 1

Details

Lead Sponsor:

Ensysce Biosciences

Treatments:

Oxycodone